SecBot SecBot
Institutional Cluster

CCCC

C4 Therapeutics, Inc.
BULLISH
Impact 6/10
Horizonweeks Processed3mo ago
Institutional cluster: 8 buyers, 1 sellers (bullish)
Actionable Insight ▲ Bullish

The institutional cluster is a strong bullish signal, but the 45-day reporting lag means positions were set at June 30 prices. Monitor for any insider open-market buying (Form 4) to confirm conviction, and watch for Phase 2 MOMENTUM enrollment completion (expected Q1 2027) as the next catalyst. The $300.4M cash runway removes near-term dilution risk.

DirectionBullish
Confidencemedium
Horizonweeks

How the stock moved after the report

⚠ Clustered BULLISH VIEWSTOCK BELOW ENTRY AT T+60
Entry
$4.27
T+0 close · Aug 14, 2026 · via day close
Latest settled
−26.14%
T+60 · $3.15
Vs SPY
−23.38%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Aug 17 $4.27entry
  2. T+1 · 3mo ago −1.99%α −1.32% · $4.18
  3. T+5 · 3mo ago −3.87%α −2.68% · $4.10
  4. T+20 · 2mo ago −19.58%α −18.05% · $3.43
  5. T+60 · 7d ago −26.14%α −23.38% · $3.15

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Eight major institutional investors, including BlackRock, State Street, and Fidelity, more than doubled their C4 Therapeutics positions in Q2 2026, adding a net $72.1M to bring aggregate holdings to $90.9M. The cluster follows a Q2 earnings beat (EPS -$0.18 vs -$0.23 consensus) and a $300.4M cash runway extending to end 2028, suggesting institutions are positioning ahead of Phase 2 MOMENTUM data expected in 2H 2027. The signal is strong but tempered by the 45-day 13F reporting lag and absence of corroborating insider open-market buying.

Key Financial Metrics

Direction
accumulating
Buy Value
$90.9M
Sell Value
$629.0K
Net Flow
$72.0M

Institutional Positions

Net institutional flow: $72.0M

▲ Buyers (8)

InstitutionActionChangePosition ValueValue Δ
BlackRockDOUBLED+285.5%$36.9M$31.5M
JPMorganADD+47.3%$20.7M$13.1M
State StreetDOUBLED+452.4%$9.9M$8.9M
GeodeDOUBLED+165.2%$11.8M$9.3M

▼ Sellers (1)

InstitutionActionChangePrev ValueValue Δ
Walleye CapitalTRIM-51.9%$629.0K-$91.2K

Key Facts

  • 8 institutions accumulated $72.1M net in Q2 2026, bringing total holdings to $90.9M
  • BlackRock doubled to 7.90M shares ($36.9M), the largest position
  • State Street quintupled to 2.12M shares ($9.9M), the largest % increase at +452%
  • Only 1 seller (Walleye Capital trimmed -$91K), negligible selling pressure
  • Q2 2026 revenue $6.6M (+2.7% YoY), EPS beat consensus by 21.7%
  • Cash $300.4M extends runway to end 2028, funding Phase 2 MOMENTUM through data readout
  • No insider open-market buying in the window, institutions-only signal

Financial Impact

8 institutions accumulated $72.1M in new positions while 1 reduced holdings by $91K, net institutional inflow of ~$72.0M

institutional_ownershipfloat_percentage

Risk Factors

  • 45-day 13F reporting lag, positions may have been unwound since quarter-end
  • No insider open-market buying to corroborate institutional conviction
  • Pre-revenue biotech with binary Phase 2 data risk in 2H 2027
  • Cluster dominated by mega-passive managers (BlackRock, State Street, Geode, Fidelity), may reflect index rebalancing, not active conviction

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
92% bullish (13 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 institutional 13F filing from SEC EDGAR.

DocumentAccession Number
INST-CLUSTER Data (Synthetic)inst-cluster-CCCC-2026-Q2

Track record

19 reports on CCCC

Performance horizon

5 of 5 bullish or bearish reports moved the stock their way by T+5. Best: +46.29% at T+60 after the Apr 9, 2026 report. 5 of 5 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $2.71 settles Nov 23
  2. Nov 12, 20264d ago 144 Neutral 2/10 Entry $2.76 settles Nov 20
  3. Nov 6, 202610d ago Institutional Cluster Neutral 2/10 Entry $3.10 to $2.76 ▼ −10.97% −13.56% vs SPY
  4. Nov 5, 202611d ago 8-K Neutral 4/10 No price data
  5. Nov 5, 202611d ago Press Release Neutral 5/10 Entry $2.95 to $2.77 ▼ −6.10% −9.39% vs SPY
  6. Sep 25, 20267w ago 8-K Neutral 4/10 Entry $2.98 to $2.95 ▼ −1.01% −0.79% vs SPY
  7. Sep 25, 20267w ago Press Release Neutral 4/10 Entry $2.98 to $2.95 ▼ −1.01% −0.79% vs SPY
  8. Aug 14, 202613w ago 144 Neutral 3/10 Entry $4.27 to $4.10 ▼ −3.87% −2.68% vs SPY
  9. Aug 14, 202613w ago Institutional Cluster Bullish 6/10 Viewing Entry $4.27 to $4.10 ▼ −3.87% −2.68% vs SPY
  10. Aug 11, 202613w ago 8-K Neutral 5/10 Entry $3.87 to $4.18 ▲ +8.01% +8.41% vs SPY
Showing 10 of 19

US Market Status

Market Closed · Opens in 6h 37m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 14, 2026